• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Co-infection withStaphylococcus aureusafter primary influenza virus infection leads to damage of the endothelium in a human alveolus-on-a-chip model

tetano

Editor, Senior Moderator
Biofabrication. 2020 Jan 27. doi: 10.1088/1758-5090/ab7073. [Epub ahead of print] [h=1]Co-infection withStaphylococcus aureusafter primary influenza virus infection leads to damage of the endothelium in a human alveolus-on-a-chip model.[/h]
Deinhardt-Emmer S[SUP]1[/SUP], Rennert K[SUP]2[/SUP], Schicke E[SUP]3[/SUP], Cseresnyes Z[SUP]4[/SUP], Windolph M[SUP]5[/SUP], Nietzsche S[SUP]6[/SUP], Heller R[SUP]7[/SUP], Siwczak F[SUP]8[/SUP], Haupt KF[SUP]9[/SUP], Carlstedt S[SUP]8[/SUP], Schacke M[SUP]9[/SUP], Figge MT[SUP]10[/SUP], Ehrhardt C[SUP]9[/SUP], Loeffler B[SUP]11[/SUP], Mosig AS[SUP]12[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Pneumonia is one of the most common infectious diseases worldwide. The influenza virus (IV) can cause severe epidemics, which results in significant morbidity and mortality. Beyond the virulence of the virus itself, epidemiological data suggest that bacterial co-infections are the major cause of increased mortality. In this context, Staphylococcus aureus represents a frequent causative bacterial pathogen. Currently, available models have several limitations in the analysis of the pathogenesis of infections, e.g., some bacterial toxins strongly act in a species-specific manner. Human 2D mono-cell culture models often fail to maintain the differentiation of alveolus-specific functions. A detailed investigation of the underlying pathogenesis mechanisms requires a physiological interaction of alveolus-specific cell types. The present work aimed to establish a human in vitro alveolus model system composed of vascular and epithelial cell structures with cocultured macrophages resembling the human alveolus architecture and functions. We demonstrate that high barrier integrity maintained for up to 14 d in our model containing functional tissue-resident macrophages. We show that flow conditions and the presence of macrophages increased the barrier function. The infection of epithelial cells induced a high inflammatory response that spread to the endothelium. Although the integrity of the epithelium was not compromised by a single infection or co-infection, we demonstrated significant endothelial cell damage associated with loss of barrier function. We established a novel immune-responsive model that reflects the complex crosstalk between pathogens and host. The in vitro model allows for the monitoring of spatiotemporal spreading of the pathogens and the characterization of morphological and functional alterations attributed to infection. The alveolus-on-a-chip represents a promising platform for mechanistic studies of host-pathogen interactions and the identification of molecular and cellular targets of novel treatment strategies in pneumonia.
Creative Commons Attribution license.


[h=4]KEYWORDS:[/h] Staphylococcus aureus; co-infection; epithelial/endothelial barrier; human alveolus-on-a-chip model; influenza virus; pneumonia

PMID: 31994489 DOI: 10.1088/1758-5090/ab7073
 
Back
Top Bottom